GenNext Technologies and Thermo Fisher Scientific Collaborate to Simplify Structural Biology for Faster Biotherapeutic Development
New Workflow Streamlines Protein Structural Analysis and Supports the Growing Role of AI in Drug Discovery
Half Moon Bay, CA – May 7, 2025 – GenNext® Technologies, Inc., a pioneer in protein footprinting, is collaborating with Thermo Fisher Scientific, the world leader in serving science, to provide a simplified structural biology workflow designed to improve biotherapeutic development. The organizations are combining GenNext’s AutoFox® Protein Footprinting System with Thermo Fisher’s industry-leading liquid chromatography-mass spectrometry (LC-MS) solutions, particularly Thermo Scientific™ Orbitrap™ instrumentation, sample preparation technology and other structural proteomics consumables, such as crosslinkers and fluorescence labels, to create a powerful, end-to-end workflow solution for researchers working on complex protein structure and drug interaction studies.
